MKI67 and neuroendocrine neoplasm: Ki-67 antigen and mitotic count represent the consensus proliferation markers for prognosis stratification among neuroendocrine neoplasms (NENs) [16], with Ki-67 recently shown to outperform mitotic count on a large cohort of lung NENs [14].